Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Creating a strong brand identity ...

Ojjaara (momelotinib) can cause side effects that range from mild to serious. More common side effects include fatigue and dizziness. If side effects from Ojjaara become difficult to tolerate ...

“There is no question that this has all the makings of a fiasco,” says Professor Andrew Wilks, who co-developed the FDA-approved, Australian-developed myelofibrosis drug Ojjaara. Adding to the anxiety ...

Is it the smoothness of running shoes or the convenience of your favourite gym shorts? Or maybe those famous logos let you know at a glance which brand you’re dealing with. In athletic apparel, logos ...

The deal is aimed at expanding GSK's portfolio in the cancer drugs manufacturing sector, taking into account the previously acquired assets of Hansoh Pharma and Sierra Oncology, which increased sales ...

Meghan's forthcoming lifestyle brand, As Ever, replaces American Riviera Orchard, and its logo features some symbolic details – one of which could be a tribute to Prince Harry's late grandmother ...

Like Queen Elizabeth, she loves horses and a great tiara moment. Meghan Markle's refreshed lifestyle brand has a logo with a meaningful symbol. On Feb. 18, the Duchess of Sussex announced that she ...

So, Ojjaara/Omjjara sales amounted to $150 million in the fourth quarter of 2024, more than tripling year-on-year. While sales of the HIV therapy called Cabenuva also did not disappoint ...

Just like the brand’s logo, the brand’s name is full of meaning, too. In an Instagram video, Meghan explained, “As Ever essentially means ‘as it’s always been,’ and if you’ve ...

Meghan Markle's refreshed lifestyle brand has a logo with a meaningful symbol. On Feb. 18, the Duchess of Sussex announced that she was rebranding her lifestyle venture previously known as ...

Oncology sales rose 72%, driven by strong patient demand for Jemperli and Ojjaara. Jemperli added £149 million to GSK’s top line compared with £130 million in third-quarter 2024, driven by new ...